Arrhythmias Clinical Trials

Find Arrhythmias Clinical Trials Near You

Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome: A Randomized Double Blind Sham Placebo-controlled Pilot Study

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This single-center study aims to evaluate both immediate and long-term outcomes of stellate ganglion block (SGB) in a cohort of rigorously phenotyped patients with Postural Tachycardia Syndrome (POTS). By assessing the effects of SGB, this study seeks to determine its viability as an intervention for symptom control in POTS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patients (\>18 years of age) diagnosed with POTS

• Ability to provide informed consent

• Ability to comply with 3 follow up visits

• English speaking and capable of signing informed consent and complying with protocol requirements

Locations
United States
California
Stanford University
RECRUITING
Stanford
Stanford University School of Medicine
RECRUITING
Stanford
Contact Information
Primary
Anna Maria Bombardieri, MD, PhD
abomba@stanford.edu
3143269107
Backup
Ksenia Kasimova, MD
kasimova@stanford.edu
6507889458
Time Frame
Start Date: 2025-10-16
Estimated Completion Date: 2027-05
Participants
Target number of participants: 20
Treatments
Experimental: Intervention Group (stellate ganglion block)
Patients will receive an ultrasound guided stellate ganglion block (SGB) with 10 ml of 0.5% ropivacaine.
Sham_comparator: Control Group (sham injection with saline)
Patients will receive a subcutaneous sham injection with saline. Ultrasound imaging will be used to simulate the guidance process as in the active procedure, maintaining consistency in the procedural experience.
Sponsors
Leads: Stanford University

This content was sourced from clinicaltrials.gov